Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 1998 |
| gptkbp:ATCCode |
gptkb:L04AC02
|
| gptkbp:contraindication |
hypersensitivity to basiliximab
|
| gptkbp:genericName |
gptkb:basiliximab
|
| https://www.w3.org/2000/01/rdf-schema#label |
Simulect
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
IL-2 receptor antagonist
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:anemia
nausea constipation hypertension peripheral edema |
| gptkbp:target |
gptkb:CD25
|
| gptkbp:usedFor |
prevention of organ rejection
|
| gptkbp:usedIn |
kidney transplantation
|
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|